5th World ADC Summit South Korea

The 5th World ADC Summit South Korea (previously World ADC Asia), taking place 9–11 June 2026 in Seoul, stands as the Asia’s premier meeting dedicated to accelerating next‑generation antibody–drug conjugate (ADC) development.

As South Korea rapidly transitions from a biosimilar‑focused market to a global innovator in precision oncology, ADCs have emerged as a centrepiece of this shift. The summit responds to this momentum by offering a comprehensive, end‑to‑end forum covering discovery, preclinical development, clinical translation, and CMC innovation. With more than 300 industry experts expected to attend, the event brings together leading organizations to exchange insights on novel and dual‑payloads, bispecific ADCs, and strategies to overcome Topo‑1 resistance and develop best‑in‑class ADCs.

Whether you are an expert or beginner in the field, join one of our three content tracks spanning early discovery through manufacturing scale‑up to get up to speed with the latest developments.

One Pass, Three Events: Part of the World Targeted Therapeutics Summit in South Korea organized by Hanson Wade, this is your opportunity to converge with peers working on targeted protein degradation (TPDs), Bispecifics, and T-cell engagers, who aim to turn South Korea into the next major global hub for biopharma innovation in targeted therapeutics.

To know more visit: https://ter.li/qznxdj